Sat, Jan 31, 2015, 12:29 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

  • gcfats gcfats Apr 16, 2013 9:06 PM Flag

    L'il Help, Longs

    Found this in IBD this past weekend. What a chart!! My question: would you all buy here? It's had a big run. If no, where would you buy some? Tx...

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • would hate to say don't buy b/c I'm an ASTX believer, but we have historically been prone to manipulation/unexplained drops. there aren't any big inflection points on the near horizon meaning we aren't expecting any big news soon (someone correct me if i'm wrong). the stock still has a high RSI so technically it would be deemed overbought. I expect a consolidation with possible pullbacks. if it goes into the 5.70's i would feel much safer.
      that said, dollar cost averaging is a good buy-in strategy.
      If sgi-110 info later in the year is good to great,and ph 3 is announced we may see $9+

      • 1 Reply to michaelplongo
      • I am a long time long, and I agree with michaelplongo. I think the value in this stock is much greater than it is now, but it requires that a lot of good things need to happen.

        The prime driver is SGI110, and that drug looks like a winner. But the drug is still only in Phase 2 trials and anything can happen, both good and bad. Aside from SGI110, the pipeline is extremely deep but nothing has completed a phase 2 trial.

        The estimate is that 1 out of 10 new drugs makes it to the market. In the case of this company, we have what looks like 4 or 5 drugs in trials and another 5 in preclinical studies. Maybe one of those ten will be approved.

        I think it will happen, but I am not putting any new money into it. Still, I want new share holders taking positions at prices much greater than this. I just don't want to make that decision for you.

8.4950.0000(0.00%)Oct 10 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
ImmunoGen, Inc.
NASDAQFri, Jan 30, 2015 4:00 PM EST Inc.
NASDAQFri, Jan 30, 2015 4:00 PM EST